eTable 3. Number and percentage of patients with at least one PIM or DDI at T0 and T1, by study arm (969 patients).
|
PIM or DDI n (%) |
PIM n (%) |
DDI n (%) |
|||||
| Study arm | Time | ||||||
| Intervention 1 (physician) (n = 247) |
T0 | 102 | 41.3 | 66 | 26.7 | 55 | 22.3 |
| T1 | 104 | 42.1 | 70 | 28.3 | 52 | 21.1 | |
| Intervention 2 (practice team) (n = 244) |
T0 | 106 | 43.4 | 69 | 28.3 | 53 | 21.7 |
| T1 | 97 | 39.8 | 66 | 27.0 | 44 | 18.0 | |
| Control (n = 478) |
T0 | 170 | 35.6 | 115 | 24.1 | 83 | 17.4 |
| T1 | 176 | 36.8 | 124 | 25.9 | 76 | 15.9 | |
DDI, undesirable drug–drug interaction; PIM, potentially inappropriate medication; T0, start of study;
T1, end of study